National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
DEA Annual Reports

2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001
20182018 Report Cover Image

T-Cell Receptor Gene Therapy for Epithelial Cancer - - T-cell receptor (TCR) gene therapy is an emerging class of cancer treatment that is based on the infusion of autologous T cells genetically engineered to express a tumor antigen-targeting TCR.

20172017 Report Cover Image

The Therapeutic Challenge of Brain Metastases of Breast Cancer - - Brain or Central Nervous System (CNS) metastases of breast cancer have become more prevlent as systemic therapies improved. For breast cancer patients whose tumor overexpresses the HER2 oncogene, 37% of metastatic patients develop brain metastases, often when they are responding to therpay or have stable systemic disease.

20162016 Report Cover Image

The Highjacking of Topoisomerases by Anticancer Drugs - - Topoisomerases exist in all forms of life where long DNA and RNA polymers are susceptible to get tangled and need to be tightly packaged, accessible in interphase, and separated during mitosis.

20152015 Report Cover Image

The RAS Initiative - The RAS family of oncogenes were the first oncogenes identified in human cancer cell DNA in 1981. Activating mutations in RAS genes, in particular KRAS, are observed in about 35 percent of lung adenocarcinomas and more than 90 percent of pancreatic cancers.

20142014 Report Cover Image

Molecular Analysis for Therapy Choice (NCI-Match): A Novel Clinical Trial - The goal of NCI-MATCH is to provide clinical evidence that a drug targeting a particular molecular profile may also be effective in the treatment of more than one tumor type.

20132013 Report Cover Image

A Precision Medicine Research Strategy - To Integrate a Taxonomic Classification of Cancer and Translate it into the Clinic. The concept that developed, that of Precision Medicine, includes four basic premises; Information Commons, Knowledge Network, Taxonomic Classifiers, and Precision Medicine.

20122012 Report Cover Image

Molecular Diagnosis of Lymphoid Malignancies - Diffuse large B cell lymphoma (DLBCL), the most common subtype of non-Hodgkin's lymphona is iagnosed in more than 20,000 individuals per year in the United States.

20112011 Report Cover Image

Deciphering the Complexity of Drug Resistance in Cancer - Cellular and molecular approaches to the study of multidrug resistance in cancer.

20102010 Report Cover Image

Personalized Immunotherapy - Identify the Cancer Antigen and Create the Anti-Tumor T Cell

20092009 Report Cover Image

Glioblastoma-Derived Tumor Stem Cells - The generation of tumor stem cell-derived neurospheres from patient-derived glioblastoma tissue.

20082008 Report Cover Image

Interleukin-15 in the Life and Death of Lymphocytes: A Target for Cancer Therapy and Vaccine Design - The structure of IL-15; A model of IL-15 receptor alpha chain (IL-15Rα) presentation of IL-15 in trans to neighboring NK and CD8+ T cells.

20072007 Report Cover Image

Identifying Interleukin-7 As a Master Regulator of T Cell Homeostasis: Clinical Implications and New Therapeutic Opportunities - Protein Data Bank Model of IL-7 Engaging the IL7R on the surface of a T cell.

20062006 Report Cover Image

The Genetic Basis of Kidney Cancer Opportunities for Disease-Specific Targeted Therapy - The genes associated with the development of cancer of the kidney have in common their interaction with pathways that control oxygen and nutrient sensing.

20052005 Report Cover Image

A Vaccine to Prevent Cervical Cancer and Other Diseases Caused by HPV Infection - 1. Authentic bovine papillomavirus virions; 2. Bovine papillomavirus-like particles; 3. Human papillomavirus-like particles; 4. 3-D reconstruction of cryo-electron micrograph of authentic papillomavirus virion (blue) coated with neutralizing antibody (red).

20042004 Report Cover Image

Molecular Imaging for Cancer - Two different types of molecular imaging techniques applied to cancer detection: positron emission tomography-computed tomography (PET-CT) fusion imaging; magnetic resonance images (MRI) using a superparamagentic imaging agent [monocrystalline iron oxide nanoparticle (MION)]

20032003 Report Cover Image

Chemical Genetics and New Treatments for Cancer - Results of screening small molecules in the cytoblot assay for their ability to cause hyperacetylation of tubulin (left) and histone (right) proteins in lung epithelial cells.

20022002 Report Cover Image

Molecular Diagnosis of Cancer - Photomicrographs of lymph node biopsies from two patients with diffuse large B cell lymphoma.

20012001 Report Cover Image

Immunotoxin Therapy of Hairy Cell Leukemia With BL22

Topup arrow